ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Genetronics Phase II Trials For Head & Neck Completed.

May 4, 2001

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

September 28, 2007

In Brief: Waxman Now Key House Health Figure; Kennedy Subcommittee Beefed Up with Top Democrats

February 9, 1979

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

Non-Profit Spent $1.3 Million On Consultants.

March 28, 2008

NCI Lists Five Comparative Effectiveness Projects For Stimulus Funds

February 6, 2009